Skip to main content
. Author manuscript; available in PMC: 2013 May 21.
Published in final edited form as: Cancer Res. 2010 Oct 5;70(20):7776–7787. doi: 10.1158/0008-5472.CAN-10-2229

Figure 2.

Figure 2

Increased T-cell infiltration in NIC/ShcAfl/fl and MT-Y250F tumors. A, relative CXCL9 and CXCL10 levels, as determined by ELISA, in lysates from NIC and NIC/ShcAfl/fl tumors. B and C, immunohistochemical staining of tumors with a CD3e-specific antibody. Data are representative of 6 (B) or 10 (C) tumors (10–20 fields per tumor) and are depicted as percentage of CD3e+ cells ± SE.